Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 140,890 | reported | 19 Jan 2022 | tx 2+355,890 |
| Climb Bio, Inc. | 40,000 | reported | 05 Jun 2026 | tx 5+110,000 |
| NEXMED INC | 16,000 | reported | 06 Jan 2021 | tx 3+56,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2026 | GRANT_AWARD | Climb Bio, Inc. | 40,000 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Climb Bio, Inc. | 40,000 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Jan 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 140,890 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 215,000 | 0.00 USD | deriv |
| 06 Jan 2021 | GRANT_AWARD | NEXMED INC | 16,000 | 0.00 USD | deriv |
| 15 May 2020 | GRANT_AWARD | NEXMED INC | 16,000 | 0.00 USD | deriv |
| 15 May 2020 | GRANT_AWARD | NEXMED INC | 24,000 | 0.00 USD | deriv |